Annabel Samimy
Stock Analyst at Stifel
(3.38)
# 944
Out of 4,876 analysts
56
Total ratings
41.67%
Success rate
26.53%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Annabel Samimy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LGND Ligand Pharmaceuticals | Initiates: Buy | $143 | $114.15 | +25.27% | 1 | Apr 10, 2025 | |
| PVLA Palvella Therapeutics | Initiates: Buy | $45 | $22.08 | +103.80% | 1 | Mar 26, 2025 | |
| GPCR Structure Therapeutics | Initiates: Buy | $50 | $21.08 | +137.19% | 1 | Jan 8, 2025 | |
| ALT Altimmune | Initiates: Buy | $18 | $3.50 | +414.29% | 1 | Jan 8, 2025 | |
| IVA Inventiva | Maintains: Buy | $20 → $17 | $3.05 | +457.38% | 4 | Nov 22, 2024 | |
| MBX MBX Biosciences | Initiates: Buy | $40 | $10.75 | +272.09% | 1 | Oct 8, 2024 | |
| KMDA Kamada | Initiates: Buy | $18 | $7.71 | +133.46% | 1 | Jul 3, 2024 | |
| PHAT Phathom Pharmaceuticals | Initiates: Buy | $24 | $9.74 | +146.41% | 1 | May 3, 2024 | |
| RGNX REGENXBIO | Maintains: Buy | $40 | $8.39 | +376.76% | 2 | Apr 12, 2024 | |
| VKTX Viking Therapeutics | Reiterates: Buy | $80 | $26.52 | +201.66% | 6 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $230 | $106.90 | +115.15% | 8 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 → $25 | $9.14 | +173.52% | 1 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $19.41 | +80.32% | 1 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $65 | $17.43 | +272.92% | 3 | Aug 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $700 → $275 | $5.22 | +5,168.20% | 4 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $13.71 | +228.23% | 1 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $8 | $0.77 | +938.96% | 1 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $0.55 | +4,247.83% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $20 | $29.64 | -32.52% | 1 | Apr 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $700 → $750 | $1.12 | +66,864.29% | 3 | Apr 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $25 → $24 | $31.16 | -22.98% | 7 | Apr 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $15 → $21 | $0.63 | +3,253.56% | 6 | Sep 18, 2019 |
Ligand Pharmaceuticals
Apr 10, 2025
Initiates: Buy
Price Target: $143
Current: $114.15
Upside: +25.27%
Palvella Therapeutics
Mar 26, 2025
Initiates: Buy
Price Target: $45
Current: $22.08
Upside: +103.80%
Structure Therapeutics
Jan 8, 2025
Initiates: Buy
Price Target: $50
Current: $21.08
Upside: +137.19%
Altimmune
Jan 8, 2025
Initiates: Buy
Price Target: $18
Current: $3.50
Upside: +414.29%
Inventiva
Nov 22, 2024
Maintains: Buy
Price Target: $20 → $17
Current: $3.05
Upside: +457.38%
MBX Biosciences
Oct 8, 2024
Initiates: Buy
Price Target: $40
Current: $10.75
Upside: +272.09%
Kamada
Jul 3, 2024
Initiates: Buy
Price Target: $18
Current: $7.71
Upside: +133.46%
Phathom Pharmaceuticals
May 3, 2024
Initiates: Buy
Price Target: $24
Current: $9.74
Upside: +146.41%
REGENXBIO
Apr 12, 2024
Maintains: Buy
Price Target: $40
Current: $8.39
Upside: +376.76%
Viking Therapeutics
Mar 15, 2024
Reiterates: Buy
Price Target: $80
Current: $26.52
Upside: +201.66%
Mar 15, 2024
Maintains: Buy
Price Target: $225 → $230
Current: $106.90
Upside: +115.15%
Mar 8, 2024
Reiterates: Buy
Price Target: $23 → $25
Current: $9.14
Upside: +173.52%
Oct 5, 2023
Initiates: Buy
Price Target: $35
Current: $19.41
Upside: +80.32%
Aug 29, 2023
Maintains: Buy
Price Target: $60 → $65
Current: $17.43
Upside: +272.92%
Jun 26, 2023
Downgrades: Hold
Price Target: $700 → $275
Current: $5.22
Upside: +5,168.20%
Mar 7, 2023
Initiates: Buy
Price Target: $45
Current: $13.71
Upside: +228.23%
Nov 10, 2022
Upgrades: Buy
Price Target: $8
Current: $0.77
Upside: +938.96%
Aug 24, 2021
Initiates: Buy
Price Target: $24
Current: $0.55
Upside: +4,247.83%
Apr 24, 2020
Initiates: Hold
Price Target: $20
Current: $29.64
Upside: -32.52%
Apr 16, 2020
Maintains: Buy
Price Target: $700 → $750
Current: $1.12
Upside: +66,864.29%
Apr 16, 2020
Maintains: Hold
Price Target: $25 → $24
Current: $31.16
Upside: -22.98%
Sep 18, 2019
Maintains: Hold
Price Target: $15 → $21
Current: $0.63
Upside: +3,253.56%